|
|
 |
|
Viewing report
|
|
|
|
Cardiac Biomarkers - Global Strategic Business Report
Global Industry Analysts, Inc., Feb 2009, Pages: 432
This report analyzes the worldwide markets for Cardiac Biomarkers in Millions of US$. The market is analyzed by Location-wise (Clinical Laboratory Testing, and Point-of-Care Testing) and by Assay type-wise (Acute Myocardial Infarction (AMI) Tests (Creatine Kinase-MB (CK-MB), Cardiac Troponin, & Myoglobin), and Congestive Heart Failure (CHF) Tests (BNP &NT-proBNP)). The report provides separate omprehensive analytics for the US, Europe, and Rest of the World. Annual forecasts are provided for each region for the period of 2006 through 2015. A five-year historic analysis is also provided for these markets.
The report profiles 78 companies including many key and niche players worldwide such as Abbott Diagnostics, Ani Biotech Oy, Axis-Shield PoC, Beckman Coulter, Inc., biomérieux, Inverness Medical Innovations, Inc., LifeSign LLC, Nanogen Inc., Ortho-Clinical Diagnostics, Inc., Oxis International, Inc., Prognostix, Inc., Response Biomedical Corp., Roche Diagnostics Corp., and Siemens Healthcare Diagnostics, Inc..Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
U.S. Cardiac Biomarkers Diagnostics Markets
Biomarkers 2008
Blood Biomarkers and Beyond: Biomarker and Diagnostic Opportunities in Cardiovascular Disease
Cardiac Markers Pipeline Technology and Market Forecasts to 2015
European Primary Care Cardiac Diagnostics Market
Strategic Assessment of the U.S. Point-of-Care Testing Markets
Proteomics - Technologies, Markets and Companies
Risk Stratification in the Diagnosis of Cardiovascular Disease
The Cardiovascular Market Outlook to 2011
The Executive Guide to Molecular Imaging
Herg: Technology and Market Analysis
Pipeline Insight: Osteoarthritis - The Wait for a DMOAD Continues
|
|
|
|
